15
Participants
Start Date
February 8, 2021
Primary Completion Date
March 13, 2024
Study Completion Date
March 13, 2024
TRL1068, a human monoclonal antibody
A human IgG1κ (G1m1,17 (z,a); Km3 allotype) monoclonal antibody
Sinai Hospital of Baltimore, Baltimore
University of Virginia, Charlottesville
University of Florida, Gainesville
Phoenix Clinical Research, Tamarac
Gulfcoast Research Institute, Sarasota
University of Alabama, Birmingham
Houston Methodist Research Institute, Houston
USC, Los Angeles
UCLA, Santa Monica
Collaborators (2)
University of California, Los Angeles
OTHER
Biomedical Advanced Research and Development Authority
FED
Wellcome Trust
OTHER
Sinai Hospital of Baltimore
OTHER
Gulfcoast Research Institute
UNKNOWN
Phoenix Clinical Research
OTHER
University of Florida
OTHER
University of Alabama at Birmingham
OTHER
The Methodist Hospital Research Institute
OTHER
University of Virginia
OTHER
University of Southern California
OTHER
Trellis Bioscience LLC
INDUSTRY